Abstract
In AIDS Clinical Trials Group A5202, participants who reported missing their medication within the past month or not providing adherence reports at both 8 and 24 weeks had 5 times the hazard of virological failure compared to more adherent participants. Adherence interventions should focus on such patients.
Author supplied keywords
Cite
CITATION STYLE
APA
Parker, R. A., Rabideau, D. J., Sax, P. E., Tierney, C., Daar, E. S., Collier, A. C., … Freedberg, K. A. (2017). Impact of medication adherence on virologic failure in A5202: A randomized, partially blinded, phase 3B study. Clinical Infectious Diseases, 64(11), 1612–1614. https://doi.org/10.1093/cid/cix176
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free